Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Chemours, Lowers Price Target to $33

Morgan Stanley Maintains Equal-Weight on Chemours, Lowers Price Target to $33

Morgan Stanley analyst Vincent Andrews maintains Chemours (NYSE:CC) with a Equal-Weight and lowers the price target from $41 to $33.

byBenzinga Newsdesk

October 25, 2022

1 minute read

Morgan Stanley analyst Vincent Andrews maintains Chemours (NYSE:CC) with a Equal-Weight and lowers the price target from $41 to $33.

Analyst Ratings

6 Analysts Have This to Say About Verizon Communications

By Benzinga Insights

July 8, 5:00 PM

Analysts have provided the following ratings for Verizon Communications (NYSE:VZ) within the last quarter:

Aditxt Forms Its Second Subsidiary, Pearsanta, Inc., To Accelerate The Growth Of Its AditxtScore Program And Appoints Healthcare Executive And Current Head Of AditxtScore Anthony Voorhies To Serve As Its President

By Happy Mohamed

February 14, 9:42 AM

AditxtScore™ continued driving revenue growth in 2022 by adding to its expanding customer base of large physician networks, healthcare systems, independent laboratories, and employer-sponsored programs. Aditxt,

ADTX

Two Harbors Investment Corp. Announces Retirement Of Chief Financial Officer Mary Riskey, Plans To Continue To Serve In Her Role Through August 1, 2024, Or Until A Successor Is Appointed By The Company

By Benzinga Newsdesk

February 5, 5:24 PM

Two Harbors Investment Corp. (NYSE:TWO), an MSR + Agency RMBS real estate investment trust, today announced that Mary Riskey intends to retire from her position as Vice President and Chief Financial Officer of the

TWO

Reported Late Thursday March 9, Faraday Future Plans To Host A Special Meeting Of Stockholders On March 30th, 2023, Announces Plans For Additional $50M Offering To Existing Shareholders

By Happy Mohamed

March 10, 1:19 AM

Affirmative vote required on March 30, 2023 special meeting of stockholders in order for the Company to receive remaining funds as contemplated in the $135 million fundraising announced on February 5, 2023;

FFIE

Morgan Stanley Maintains Equal-Weight on Chemours, Lowers Price Target to $33

Related Posts

6 Analysts Have This to Say About Verizon Communications

Aditxt Forms Its Second Subsidiary, Pearsanta, Inc., To Accelerate The Growth Of Its AditxtScore Program And Appoints Healthcare Executive And Current Head Of AditxtScore Anthony Voorhies To Serve As Its President

Two Harbors Investment Corp. Announces Retirement Of Chief Financial Officer Mary Riskey, Plans To Continue To Serve In Her Role Through August 1, 2024, Or Until A Successor Is Appointed By The Company

Reported Late Thursday March 9, Faraday Future Plans To Host A Special Meeting Of Stockholders On March 30th, 2023, Announces Plans For Additional $50M Offering To Existing Shareholders